Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-075081·ARK Investment Management LLC
Schedule 13G ownership disclosure
Beam Therapeutics Inc
Common Stock · CUSIP: 07373V105
Event date: 2025-07-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ARK Investment Management LLC
Shares: 10,410,137.00 · Class: 10.35%
- Catherine D. Wood
Shares: 10,410,137.00 · Class: 10.35%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-075081
- Form type
- SCHEDULE 13G/A
- Filer
- ARK Investment Management LLC
- CIK
- CIK 1697748
- Filed
- Aug 07, 2025
- Reporting period
- Jul 31, 2025
- Description
- Schedule 13G beneficial ownership